Morphine Extended-Release Capsules and Zoledronic acid
Determining the interaction of Morphine Extended-Release Capsules and Zoledronic acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Morphine Extended-Release Capsules-Zoledronic Acid (Bone Health)
- Morphine Extended-Release Capsules-Zoledronic Acid (Zometa)
- Morphine Extended-Release Capsules-Zoledronic Acid Injection
- Morphine Extended-Release Capsules-Zoledronic Acid Injection Concentrate
- Morphine Extended-Release Capsules-Zoledronic acid Intravenous
- Morphine Extended-Release Capsules-Zoledronic Acid IV
- Zoledronic acid-Morphine Immediate-Release Tablets and Capsules
- Zoledronic acid-Morphine injection
- Zoledronic acid-Morphine Injection PF
- Zoledronic acid-Morphine Long-Acting Tablets
- Zoledronic acid-Morphine Oral Concentrate (20 mg/mL)
- Zoledronic acid-Morphine Oral Solution